Asep Inc. Completes Submission of Registration Statement for NASDAQ Listing by asepadmin | Jul 5, 2023 | Uncategorized
Asep Inc. Receives Grant from NanoMedicines Innovation Network (NMIN), Funded by the Government of Canada The New Grant Will Support Important Pre-clinical Studies by asepadmin | Jun 26, 2023 | Uncategorized
Asep Inc. Founder, Chair and CEO, Dr. Robert E. W. Hancock, Ranked 4th Best Microbiologist in the World by asepadmin | Jun 20, 2023 | Uncategorized
Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa by asepadmin | Jun 12, 2023 | Uncategorized
Asep Inc. Announces Ground-breaking A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies by asepadmin | Jun 5, 2023 | Uncategorized
